
Bioorganic and Medicinal Chemistry p. 2379 - 2384 (2008)
Update date:2022-07-29
Topics:
Gitto, Rosaria
De Luca, Laura
Pagano, Benedetta
Citraro, Rita
De Sarro, Giovanbattista
Costa, Lara
Ciranna, Lucia
Chimirri, Alba
In our previous studies a ligand-based approach led to the identification of noncompetitive AMPA receptor antagonists containing isoquinoline scaffold. In an attempt to perform a systematic SAR study, we synthesized new N-substituted-isoquinolines bearing the most salient features described by our 3D pharmacophore model. All compounds were screened against audiogenic seizures and some derivatives showed anticonvulsant properties. Compound 24, the most active of the series, was also tested in vitro using the patch-clamp technique and proved to antagonize AMPA-mediated effects.
Shanghai Coupling Pharmaceutical R&D Co., Ltd.(expird)
Contact:+86 021 50106671
Address:403 Room No.4 Buiding, No. 526 Ruiqing Road, Shanghai Zhangjiang Hi-Tech Park
Huangshan Violet Biological Technology Co., Ltd
Contact:+86-559-2335676
Address:16-201 JinShanYuan,JiangNan New City,TunXi District,HuangShan City,AnHui Province,China
Shenyang NovPharm Technology Co., Ltd.
Contact:.+86-24-24165786
Address:Room 306, Hongjin Mansion, No. 36-1, Wanliutang Rd., Shenhe District, Shenyang, Liaoning, P.R.C.
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
website:http://www.konochem.com
Contact:86-29-86107037
Address:No.170 West Avenue,Xi’an 710082,China
Doi:10.1016/j.tetlet.2009.02.136
(2009)Doi:10.1021/jo00362a021
(1986)Doi:10.1016/S0040-4039(01)80851-0
(1985)Doi:10.1016/j.poly.2007.12.034
(2008)Doi:10.1021/ja00273a028
(1986)Doi:10.1021/acs.jmedchem.6b00738
(2016)